A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Riociguat Impurity 29 - Request Quote

Picture of Riociguat Impurity 29

Riociguat Impurity 29

SZ CAT No:SZ-R014037
CAS No
NA
Mol.F.
C28H21F2N9
Mol.Wt.
521.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Riociguat Impurity 29 is chemically (E)-N-(amino(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)methylene)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide. Riociguat Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Riociguat Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Riociguat.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Riociguat Impurity 29

Purchase Riociguat Impurity 29

Riociguat Impurity 29 suppliers

Riociguat Impurity 29 manufacturers

Riociguat Impurity 29 price

Order Riociguat Impurity 29

Enquire Riociguat Impurity 29

Riociguat Impurity 29 cost

Riociguat Impurity 29 Supplier

Riociguat Impurity 29 Distributor

Riociguat Impurity 29 for Method Validation

Riociguat Reference Standard

Riociguat Impurity 29 for ANDA Filing

Riociguat Impurity 29 for Forced Degradation Studies

Riociguat Impurity 29 Identification Standards

Riociguat Impurity 29 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,